Spruce Biosciences, Inc.
SPRBD
$8.20
-$0.30-3.53%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -48.34M | -55.45M | -53.04M | -39.43M | -43.11M |
| Total Depreciation and Amortization | 32.00K | 37.00K | 46.00K | 53.00K | 60.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.21M | 4.43M | 5.60M | 5.79M | 5.63M |
| Change in Net Operating Assets | -5.36M | -2.74M | -8.57M | -12.91M | -12.12M |
| Cash from Operations | -51.46M | -53.73M | -55.96M | -46.50M | -49.54M |
| Capital Expenditure | -- | -- | -- | 0.00 | -7.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 9.30M | 23.30M |
| Cash from Investing | -- | -- | -- | 9.30M | 23.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.62M | -1.62M | -1.62M | -1.62M | -1.62M |
| Issuance of Common Stock | 14.00K | 66.00K | 246.00K | 303.00K | 303.00K |
| Repurchase of Common Stock | -233.00K | -244.00K | -246.00K | -230.00K | -230.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -6.00K | -- | 0.00 | 0.00 |
| Cash from Financing | -1.84M | -1.81M | -1.62M | -1.55M | -1.55M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -53.30M | -55.54M | -57.59M | -38.75M | -27.80M |